Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

4405 ARTÍCULOS , VIENDO DEL 1141 AL 1155

Comorbidity burden of patients with Parkinson's disease and Parkinsonism between 2003 and 2012: A multicentre, nationwide, retrospective study in China

Wang X, Zeng F, Jin WS, Zhu C, Wang QH, Bu XL, Luo HB, Zou HQ, Pu J, Zhou ZH, Cui XP, Wang QS, Shi XQ, Han W, Wu Q, Chen HS, Lin H, Zhang LL, Zhang M, Lian Y, Xu ZQ, Zhou HD, Zhang T, Wang YJ.

Sci Rep. 2017 May 10;7(1):1671. doi: 10.1038/s41598-017-01795-0.

Atrial fibrillation associated with Wolff-Parkinson-White syndrome in a patient with concomitant Brugada syndrome

Shi S, Liu T, Barajas-Martinez H, Pfeiffer R, Jiang H, Huang C, Hu D.

HeartRhythm Case Rep. 2017 Jan 3;3(1):13-17. doi: 10.1016/j.hrcr.2016.12.001. eCollection 2017 Jan.

Orthoptic Treatment of Convergence Insufficiency in Parkinson's Disease: A Case Series

Kergoat H, Law C, Chriqui E, Kergoat MJ, Leclerc BS, Panisset M, Postuma R, Irving EL.

Gerontol Geriatr Med. 2017 Apr 11;3:2333721417703735. doi: 10.1177/2333721417703735. eCollection 2017 Jan-Dec.

The Role of Amantadine Withdrawal in 3 Cases of Treatment-Refractory Altered Mental Status

Fryml LD, Williams KR, Pelic CG, Fox J, Sahlem G, Robert S, Revuelta GJ, Short EB.

J Psychiatr Pract. 2017 May;23(3):191-199. doi: 10.1097/PRA.0000000000000237.

The US Food and Drug Administration's Perspective on the New Antipsychotic Pimavanserin

Mathis MV, Muoio BM, Andreason P, Avila AM, Farchione T, Atrakchi A, Temple RJ.

J Clin Psychiatry. 2017 Jun;78(6):e668-e673. doi: 10.4088/JCP.16r11119.

Integrated analysis of droxidopa trials for neurogenic orthostatic hypotension

Biaggioni I, Arthur Hewitt L, Rowse GJ, Kaufmann H.

BMC Neurol. 2017 May 12;17(1):90. doi: 10.1186/s12883-017-0867-5.

α-Synuclein may cross-bridge v-SNARE and acidic phospholipids to facilitate SNARE-dependent vesicle docking

Lou X, Kim J, Hawk BJ, Shin YK.

Biochem J. 2017 Jun 6;474(12):2039-2049. doi: 10.1042/BCJ20170200.

[Pharmacotherapy of Parkinson's disease : Aspects of drug safety]

Müller-Rebstein S, Trenkwalder C, Oertel WH, Culmsee C, Eckermann G, Höglinger GU.

Nervenarzt. 2017 Aug;88(8):888-894. doi: 10.1007/s00115-017-0345-8.

Deep Brain Stimulation Emergencies: How the New Technologies Could Modify the Current Scenario

Cossu G, Sensi M.

Curr Neurol Neurosci Rep. 2017 Jul;17(7):51. doi: 10.1007/s11910-017-0761-y.

The correlation of lymphocyte subsets, natural killer cell, and Parkinson's disease: a meta-analysis

Jiang S, Gao H, Luo Q, Wang P, Yang X.

Neurol Sci. 2017 Aug;38(8):1373-1380. doi: 10.1007/s10072-017-2988-4. Epub 2017 May 11.

Shaking Up the Debate: Ensuring the Ethical Use of DBS Intervention Criteria for Mid-Stage Parkinson's Patients

Eijkholt M, Cabrera LY, Ramirez-Zamora A, Pilitsis JG.

Neuromodulation. 2017 Jul;20(5):411-416. doi: 10.1111/ner.12608. Epub 2017 May 11.

Electrical stimulation of the dorsal columns of the spinal cord for Parkinson's disease

Yadav AP, Nicolelis MAL.

Mov Disord. 2017 Jun;32(6):820-832. doi: 10.1002/mds.27033. Epub 2017 May 12.

Protein Misfolding, Amyloid Formation, and Human Disease: A Summary of Progress Over the Last Decade

Chiti F, Dobson CM.

Annu Rev Biochem. 2017 Jun 20;86:27-68. doi: 10.1146/annurev-biochem-061516-045115. Epub 2017 May 12.

Radiological biomarkers for diagnosis in PSP: Where are we and where do we need to be?

Whitwell JL, Höglinger GU, Antonini A, Bordelon Y, Boxer AL, Colosimo C, van Eimeren T, Golbe LI, Kassubek J, Kurz C, Litvan I, Pantelyat A, Rabinovici G, Respondek G, Rominger A, Rowe JB, Stamelou M, Josephs KA; Movement Disorder Society-endorsed PSP Study Group.

Mov Disord. 2017 Jul;32(7):955-971. doi: 10.1002/mds.27038. Epub 2017 May 13.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias